{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:45:09Z","timestamp":1791287109358,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The role of fatty acids in coronary heart disease (CHD) remains uncertain. There is little evidence from large-scale epidemiological studies on the relevance of circulating fatty acids levels to CHD risk. This study aims to examine the independent associations of the major circulating types of fatty acids with CHD risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>UK Biobank is a prospective study of adults aged 40\u201369 in 2006\u20132010; in 2012\u20132013, a subset of the participants were resurveyed. Analyses were restricted to 89,242 participants with baseline plasma fatty acids (measured using nuclear magnetic resonance spectroscopy) and without prior CHD. Cox proportional hazards models were used to estimate hazard ratios (HRs) for the associations with incidence CHD, defined as the first-ever myocardial infarction, unstable angina pectoris, coronary-related death, or relevant procedure. And the major types of fatty acids were mutually adjusted to examine the independent associations. Hazard ratios were corrected for regression dilution using the correlation of baseline and resurvey fatty acids measures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During a median follow-up of 11.8 years, 3,815 incident cases of CHD occurred. Independently of other fatty acids, CHD risk was positively associated with saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA), inversely associated with omega-3 polyunsaturated fatty acids (PUFA), but there was no strong evidence of an association with omega-6 PUFA: HR per standard deviation higher were 1.14 (95% CI, 1.09\u20131.20), 1.15 (1.10\u20131.21), 0.91 (0.87\u20130.94), and 1.04 (0.99\u20131.09) respectively. Independently of triglycerides and cholesterol, the inverse association with omega-3 PUFA was not materially changed, but the positive associations with SFA and MUFA attenuated to null after adjusting for triglycerides levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This large-scale study has quantitated the independent associations of circulating fatty acids with CHD risk. Omega-3 PUFA was inversely related to CHD risk, independently of other fatty acids and major lipid fractions. By contrast, independently of other fatty acids, the positive associations of circulating SFA and MUFA with CHD risk were mostly attributed to their relationship with triglycerides.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03394-6","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T13:02:17Z","timestamp":1689944537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Associations of circulating fatty acids with incident coronary heart disease: a prospective study of 89,242 individuals in UK Biobank"],"prefix":"10.1186","volume":"23","author":[{"given":"Danyao","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Trichia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazrul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lewington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"3394_CR1","unstructured":"Organization WH. Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO\/FAO expert consultation. Volume 916. World Health Organization; 2003."},{"issue":"29","key":"3394_CR2","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, et al. 2016 european guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315\u201381.","journal-title":"Eur Heart J"},{"issue":"3","key":"3394_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000000510","volume":"136","author":"FM Sacks","year":"2017","unstructured":"Sacks FM, Lichtenstein AH, Wu JHY, et al. Dietary Fats and Cardiovascular Disease: a Presidential Advisory from the American Heart Association. Circulation. 2017;136(3):e1\u2013e23.","journal-title":"Circulation"},{"issue":"5","key":"3394_CR4","first-page":"Cd011737","volume":"5","author":"L Hooper","year":"2020","unstructured":"Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020;5(5):Cd011737.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3394_CR5","doi-asserted-by":"publisher","first-page":"e1000252","DOI":"10.1371\/journal.pmed.1000252","volume":"7","author":"D Mozaffarian","year":"2010","unstructured":"Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7(3):e1000252.","journal-title":"PLoS Med"},{"key":"3394_CR6","doi-asserted-by":"publisher","first-page":"e8707","DOI":"10.1136\/bmj.e8707","volume":"346","author":"CE Ramsden","year":"2013","unstructured":"Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:e8707.","journal-title":"BMJ"},{"key":"3394_CR7","doi-asserted-by":"publisher","first-page":"i1246","DOI":"10.1136\/bmj.i1246","volume":"353","author":"CE Ramsden","year":"2016","unstructured":"Ramsden CE, Zamora D, Majchrzak-Hong S, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary experiment (1968-73). BMJ. 2016;353:i1246.","journal-title":"BMJ"},{"issue":"2","key":"3394_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5507\/bp.2011.038","volume":"155","author":"E Tvrzicka","year":"2011","unstructured":"Tvrzicka E, Kremmyda LS, Stankova B, Zak A. Fatty acids as biocompounds: their role in human metabolism, health and disease\u2013a review. Part 1: classification, dietary sources and biological functions. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(2):117\u201330.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"3394_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev.nutr.25.051804.101917","volume":"25","author":"H Sampath","year":"2005","unstructured":"Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr. 2005;25:317\u201340.","journal-title":"Annu Rev Nutr"},{"issue":"5","key":"3394_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jacc.2020.11.060","volume":"77","author":"RL Weinberg","year":"2021","unstructured":"Weinberg RL, Brook RD, Rubenfire M, Eagle KA. Cardiovascular Impact of Nutritional Supplementation with Omega-3 fatty acids: JACC Focus Seminar. J Am Coll Cardiol. 2021;77(5):593\u2013608.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3394_CR11","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/eurheartj\/ehn049","volume":"29","author":"R Clarke","year":"2008","unstructured":"Clarke R, Emberson JR, Breeze E, et al. Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J. 2008;29(6):800\u20139.","journal-title":"Eur Heart J"},{"issue":"4","key":"3394_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","volume":"150","author":"R Clarke","year":"1999","unstructured":"Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341\u201353.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"3394_CR13","doi-asserted-by":"publisher","first-page":"e013131","DOI":"10.1161\/JAHA.119.013131","volume":"9","author":"MC Borges","year":"2020","unstructured":"Borges MC, Schmidt AF, Jefferis B, et al. Circulating fatty acids and risk of Coronary Heart Disease and Stroke: individual Participant Data Meta-Analysis in Up to 16 126 participants. J Am Heart Assoc. 2020;9(5):e013131.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"3394_CR14","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/jamainternmed.2016.2925","volume":"176","author":"LC Del Gobbo","year":"2016","unstructured":"Del Gobbo LC, Imamura F, Aslibekyan S, et al. \u03c9-3 polyunsaturated fatty acid biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. JAMA Intern Med. 2016;176(8):1155\u201366.","journal-title":"JAMA Intern Med"},{"issue":"7726","key":"3394_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139.","journal-title":"Nature"},{"issue":"3","key":"3394_CR16","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"1","key":"3394_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","volume":"8","author":"P Soininen","year":"2015","unstructured":"Soininen P, Kangas AJ, W\u00fcrtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circulation Cardiovasc Genet. 2015;8(1):192\u2013206.","journal-title":"Circulation Cardiovasc Genet"},{"issue":"9","key":"3394_CR18","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/aje\/kwx016","volume":"186","author":"P W\u00fcrtz","year":"2017","unstructured":"W\u00fcrtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -Omic Technologies. Am J Epidemiol. 2017;186(9):1084\u201396.","journal-title":"Am J Epidemiol"},{"key":"3394_CR19","unstructured":"Nightingale Health Metabolic Biomarkers: Phase 1 Release. 2020. https:\/\/biobank.ndph.ox.ac.uk\/showcase\/ukb\/docs\/nmrm_companion_doc.pdf. Accessed Dec 13, 2021."},{"issue":"5","key":"3394_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.plipres.2008.03.003","volume":"47","author":"L Hodson","year":"2008","unstructured":"Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47(5):348\u201380.","journal-title":"Prog Lipid Res"},{"key":"3394_CR21","unstructured":"Health NCf H, Do, Centre SCI. OPCS classifications of interventions and procedures. Volume 1. The Stationery Office; 2006."},{"key":"3394_CR22","unstructured":"Yousaf S, Bonsall A. UK Townsend Deprivation Scores from 2011 Census Data. 2017; http:\/\/s3-eu-west-1.amazonaws.com\/statistics.digitalresources.jisc.ac.uk\/dkan\/files\/Townsend_Deprivation_Scores\/UK%20Townsend%20Deprivation%20Scores%20from%202011%20census%20data.pdf. Accessed 13 Dec 2021."},{"issue":"7","key":"3394_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/sim.4780100703","volume":"10","author":"DF Easton","year":"1991","unstructured":"Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med. 1991;10(7):1025\u201335.","journal-title":"Stat Med"},{"issue":"1","key":"3394_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/sim.1485","volume":"23","author":"M Plummer","year":"2004","unstructured":"Plummer M. Improved estimates of floating absolute risk. Stat Med. 2004;23(1):93\u2013104.","journal-title":"Stat Med"},{"issue":"21","key":"3394_CR25","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1161\/CIRCULATIONAHA.118.038908","volume":"139","author":"M Marklund","year":"2019","unstructured":"Marklund M, Wu JHY, Imamura F, et al. Biomarkers of Dietary Omega-6 fatty acids and Incident Cardiovascular Disease and Mortality. Circulation. 2019;139(21):2422\u201336.","journal-title":"Circulation"},{"issue":"6","key":"3394_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.7326\/M13-1788","volume":"160","author":"R Chowdhury","year":"2014","unstructured":"Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398\u2013406.","journal-title":"Ann Intern Med"},{"issue":"9","key":"3394_CR27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.114.013116","volume":"131","author":"P W\u00fcrtz","year":"2015","unstructured":"W\u00fcrtz P, Havulinna AS, Soininen P, et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 2015;131(9):774\u201385.","journal-title":"Circulation"},{"issue":"5","key":"3394_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/ajcn\/74.5.585","volume":"74","author":"M Garaulet","year":"2001","unstructured":"Garaulet M, P\u00e9rez-Llamas F, P\u00e9rez-Ayala M, et al. Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am J Clin Nutr. 2001;74(5):585\u201391.","journal-title":"Am J Clin Nutr"},{"issue":"18","key":"3394_CR29","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.114.010236","volume":"130","author":"MS Farvid","year":"2014","unstructured":"Farvid MS, Ding M, Pan A, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 2014;130(18):1568\u201378.","journal-title":"Circulation"},{"issue":"5","key":"3394_CR30","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3945\/ajcn.2008.27124","volume":"89","author":"MU Jakobsen","year":"2009","unstructured":"Jakobsen MU, O\u2019Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89(5):1425\u201332.","journal-title":"Am J Clin Nutr"},{"key":"3394_CR31","unstructured":"Fats. and fatty acids in human nutrition. Report of an expert consultation. FAO Food Nutr Pap. 2010;91:1-166."},{"issue":"1","key":"3394_CR32","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/CIR.0000000000000574","volume":"138","author":"EB Rimm","year":"2018","unstructured":"Rimm EB, Appel LJ, Chiuve SE, et al. Seafood Long-Chain n-3 polyunsaturated fatty acids and Cardiovascular Disease: A Science Advisory from the American Heart Association. Circulation. 2018;138(1):e35\u2013e47.","journal-title":"Circulation"},{"issue":"19","key":"3394_CR33","doi-asserted-by":"publisher","first-page":"e013543","DOI":"10.1161\/JAHA.119.013543","volume":"8","author":"Y Hu","year":"2019","unstructured":"Hu Y, Hu FB, Manson JE. Marine Omega-3 Supplementation and Cardiovascular Disease: an updated Meta-analysis of 13 randomized controlled trials involving 127 477 participants. J Am Heart Assoc. 2019;8(19):e013543.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"3394_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","volume":"3","author":"T Aung","year":"2018","unstructured":"Aung T, Halsey J, Kromhout D, et al. Associations of Omega-3 fatty acid supplement Use with Cardiovascular Disease Risks: Meta-analysis of 10 trials involving 77 917 individuals. JAMA Cardiol. 2018;3(3):225\u201334.","journal-title":"JAMA Cardiol"},{"issue":"22","key":"3394_CR35","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1001\/jama.2020.22258","volume":"324","author":"SJ Nicholls","year":"2020","unstructured":"Nicholls SJ, Lincoff AM, Garcia M, et al. Effect of high-dose Omega-3 fatty acids vs corn oil on major adverse Cardiovascular events in patients at High Cardiovascular Risk: the STRENGTH Randomized Clinical Trial. JAMA. 2020;324(22):2268\u201380.","journal-title":"JAMA"},{"issue":"1","key":"3394_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","volume":"380","author":"DL Bhatt","year":"2019","unstructured":"Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11\u201322.","journal-title":"N Engl J Med"},{"issue":"16","key":"3394_CR37","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1804989","volume":"379","author":"L Bowman","year":"2018","unstructured":"Bowman L, Mafham M, Wallendszus K, et al. Effects of n-3 fatty acid supplements in diabetes Mellitus. N Engl J Med. 2018;379(16):1540\u201350.","journal-title":"N Engl J Med"},{"issue":"6","key":"3394_CR38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.120.052209","volume":"143","author":"AA Kalstad","year":"2021","unstructured":"Kalstad AA, Myhre PL, Laake K, et al. Effects of n-3 fatty acid supplements in Elderly Patients after myocardial infarction: a Randomized, Controlled Trial. Circulation. 2021;143(6):528\u201339.","journal-title":"Circulation"},{"issue":"1","key":"3394_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1811403","volume":"380","author":"JE Manson","year":"2019","unstructured":"Manson JE, Cook NR, Lee IM, et al. Marine n-3 fatty acids and Prevention of Cardiovascular Disease and Cancer. N Engl J Med. 2019;380(1):23\u201332.","journal-title":"N Engl J Med"},{"issue":"9567","key":"3394_CR40","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","volume":"369","author":"M Yokoyama","year":"2007","unstructured":"Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (London England). 2007;369(9567):1090\u20138.","journal-title":"Lancet (London England)"},{"issue":"2","key":"3394_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1017\/S0029665111000061","volume":"70","author":"SC Cottin","year":"2011","unstructured":"Cottin SC, Sanders TA, Hall WL. The differential effects of EPA and DHA on cardiovascular risk factors. Proc Nutr Soc. 2011;70(2):215\u201331.","journal-title":"Proc Nutr Soc"},{"key":"3394_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2022.11.008","volume":"257","author":"Y Nishizaki","year":"2023","unstructured":"Nishizaki Y, Miyauchi K, Iwata H, et al. Study protocol and baseline characteristics of Randomized trial for evaluation in secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of a randomized control trial and an observational biomarker study. Am Heart J. 2023;257:1\u20138.","journal-title":"Am Heart J"},{"issue":"1","key":"3394_CR43","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12916-022-02399-w","volume":"20","author":"MC Borges","year":"2022","unstructured":"Borges MC, Haycock PC, Zheng J, et al. Role of circulating polyunsaturated fatty acids on cardiovascular diseases risk: analysis using mendelian randomization and fatty acid genetic association data from over 114,000 UK Biobank participants. BMC Med. 2022;20(1):210.","journal-title":"BMC Med"},{"issue":"20","key":"3394_CR44","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","volume":"58","author":"D Mozaffarian","year":"2011","unstructured":"Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20):2047\u201367.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3394_CR45","doi-asserted-by":"publisher","first-page":"e0218549","DOI":"10.1371\/journal.pone.0218549","volume":"14","author":"R Li-Gao","year":"2019","unstructured":"Li-Gao R, Hughes DA, le Cessie S, et al. Assessment of reproducibility and biological variability of fasting and postprandial plasma metabolite concentrations using 1H NMR spectroscopy. PLoS ONE. 2019;14(6):e0218549.","journal-title":"PLoS ONE"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03394-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03394-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03394-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T13:04:05Z","timestamp":1689944645000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03394-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3394"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03394-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"3 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SL reports grants from the Medical Research Council (MRC) and research funding from the US Centers for Disease Control and Prevention Foundation (with support from Amgen) and from the World Health Organization during the conduct of the study, all outside the submitted work. Other remaining authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval for the UK Biobank study was given by the National Health Service North West Multicentre Research Ethics Committee. All participants provided informed written consent to take part in the study. All experiments were performed in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"365"}}